New hope for kids with Chemo-Induced low platelets: drug shows promise
NCT ID NCT07043894
First seen May 08, 2026 · Last updated Jun 09, 2026 · Updated 5 times
Summary
This study tests a drug called romiplostim N01 to help children and young adults (ages 6-24) with cancer whose platelet counts drop dangerously low after chemotherapy. Low platelets can cause bleeding and delay treatment. The drug is given as a weekly shot to boost platelet production. Researchers will check how many patients recover safe platelet levels within 3 weeks and monitor for side effects like bleeding or clots. About 50 participants will take part in this single-arm study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.